Form 4: TransDigm COO sells shares after option exercise
Insider Transaction (Form 4)
TransDigm Co-COO Joel Reiss exercised 3,900 options at $284.97 and sold the resulting shares via a Rule 10b5-1 plan, reducing direct holdings to 3,600 shares.
Summary
- Joel Reiss, Co-Chief Operating Officer of TransDigm Group (TDG), reported transactions dated 11/17/2025 under a Rule 10b5-1 trading plan.
- Exercised 3,900 stock options at an exercise price of $284.97 per share and acquired 3,900 common shares (transaction code M).
- Sold 3,900 common shares in multiple open market tranches on 11/17/2025 at weighted-average prices ranging from approximately $1,326.16 to $1,354.9199 (transaction code S).
- Direct beneficial ownership changed from 7,500 to 3,600 common shares after the sales.
- Remaining derivative securities (stock options) after the transactions total 43,100.
- The exercised option was first exercisable on 09/30/2021 and expires on 11/08/2027.
- Form signed by attorney-in-fact Rachel Quinlan on 11/18/2025.
Sentiment
Score: 5
Explanation: Routine 10b5-1 option exercise and sale by an executive; neutral signal with no operational or financial performance implications disclosed.
Positives
- Transactions conducted pursuant to a Rule 10b5-1(c) trading plan, indicating pre-arranged, systematic trading.
- Executive retains 3,600 directly owned shares following the sales.
- Executive continues to hold 43,100 stock options after the reported transactions.
Negatives
- Net selling of 3,900 shares on 11/17/2025, reducing direct holdings from 7,500 to 3,600 shares.
- All shares acquired through option exercise were sold the same day in multiple tranches.
Future Outlook
No forward-looking statements or guidance provided.
Industry Context
Insider trading reports like this Form 4 are routine across aerospace and defense suppliers; sales executed under Rule 10b5-1 plans are common governance practices to reduce perceived informational timing risk.
Comparison to Industry Standards
- Use of Rule 10b5-1 trading plans is in line with practices among large U.S. aerospace/defense companies (e.g., HEICO, RTX, GE Aerospace) for scheduled executive trading.
- Option exercise-and-sell transactions are a standard approach for executives to cover tax/liquidity needs without implying operational commentary.
Stakeholder Impact
- Executive reduced direct holdings by 3,900 shares to 3,600 shares.
- Transactions were executed under a Rule 10b5-1 plan, providing pre-arranged trading structure.
- Executive retains 43,100 options, maintaining equity-linked exposure.
Key Dates
| Date | Description |
|---|---|
| 09/30/2021 | Option first exercisable date |
| 11/08/2027 | Option expiration date |
| 11/17/2025 | Transaction date (option exercise and sales) |
| 11/18/2025 | Form signed by attorney-in-fact |
Keywords
TransDigm Group, TDG, Form 4, insider transaction, Rule 10b5-1 plan, stock option exercise, insider selling, aerospace, Joel Reiss, executive trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.